TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Rating)’s stock price traded down 4.5% on Monday . The stock traded as low as $36.72 and last traded at $36.72. 206,738 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 1,132,112 shares. The stock had previously closed at $38.46. Analyst Ratings […]
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Rating) shares shot up 5.3% during mid-day trading on Wednesday . The stock traded as high as $38.46 and last traded at $38.46. 96,563 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 1,163,001 shares. The stock had previously closed at $36.54. […]
Guggenheim Capital LLC reduced its stake in Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Rating) by 23.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 24,340 shares of the biotechnology company’s stock after selling 7,570 shares during the quarter. Guggenheim Capital LLC’s holdings in Mirati […]